KMT2D and cervical carcinoma: In a study by Lee et al., utilizing NGS of 24 different mutations, 75 percent of 24 cervical cancer patients were found to harbor these mutations, and in greater than 75% of the time these mutations were found in ZFHX3, KMT2C, and KMT2D [68].